PARKHOSPSBSEPARK MEDI WORLD LIMITEDMediumNeutral
Announced Sat, 8 Aug · 15:55 IST

Park Medi Q1 FY27: Revenue up 19%, PAT up 35%, 5,740 Beds Target by FY28

Mgmt Guided Margin ImprovementPromoter Disclosed Acquisition PlansOrder Pipeline DisclosedAnalyst Day Multiyear TargetsCfo Debt Reduction RoadmapInvestor Communications View source PDFExplain this filing

PARKHOSPS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.9%1-day move
₹291.20
prior close
₹295.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.5-0.4-0.5-0.7-2.9-2.9-3.6-3.2-5.2-6.5
Up moveDown movePending
AI summary

Park Medi World Q1 FY27: revenue Rs.476 cr (up 19% YoY), EBITDA Rs.126 cr at 26.5% margin, PAT Rs.89 cr up 35% YoY. Bed capacity 3,960, up 32% YoY. FY27 guidance: revenue Rs.2,080 cr, EBITDA Rs.530 cr, PAT Rs.360 cr. Acquired Rudrapur (Rs.177 cr, 330 beds) and Zirakpur (Rs.107 cr, 150 beds) plus Palam Vihar expansion. Targeting 5,740 beds by FY28 funded by internal accruals and IPO proceeds, no fresh debt. ARPOB guided 10-12%.

Likely market impact

Strong 24-32% growth guidance, debt-free expansion via acquisitions and bed additions, plus margin stability reinforce positive FY27 outlook.